ChartRow logo
GENI
$6.32-3.07%
as of close, Oct 27, 2026
☾ AH $6.32 -3.07%
Genius Sports LimitedStock · Communication ServicesRussell 2000 · 0.05% of IWMRussell 3000 · 0.002% of IWV
PeersMETAGOOGLNBISNFLXAPPVZ
Share this page

GENI financial statements

The full income statement, balance sheet, and cash-flow statement for Genius Sports Limited (GENI), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue669M+31.0%511M+23.7%413M+21.1%341M+29.8%263M+75.5%
154M+19.5%129M+86.5%69.0M+2310.2%2.86M+101.3%-213M-698.3%
Cost of revenue516M+34.9%382M+11.1%344M+1.7%338M-29.0%476M+317.4%
305M+63.0%187M+30.8%143M-22.9%186M-48.4%360M+534.5%
Research & development31.1M+26.5%24.6M-5.7%26.1M-12.8%29.9M+12.8%26.5M+135.9%
Selling, general & administrative208M+69.1%123M+44.4%85.2M-30.7%123M-58.1%293M+827.1%
General & administrative208M+69.1%123M+44.4%85.2M-30.7%123M-58.1%293M+827.1%
Selling & marketing56.2M+50.1%37.4M+27.1%29.4M-6.1%31.3M+14.8%27.3M+107.1%
Amortization of intangibles62.5M-5.4%66.1M-8.4%72.2M+13.2%63.8M+13.3%56.3M+68.6%
Provision for credit losses1.91M+17.1%1.63M-35.3%2.52M+15.2%2.19M+49.2%1.47M+217.1%
Operating income-151M-158.5%-58.5M+21.1%-74.2M+59.4%-183M+68.1%-573M-2625.0%
Net interest income-6.00K-100.7%921K-52.8%1.95M+231.3%-1.49M+55.4%-3.33M+57.7%
Other non-operating income33.6M+535.1%-7.72M+15.5%-9.14M-2140.7%-408K+98.7%-31.2M-315.7%
Equity-method income3.66M-1.9%3.73M+20.0%3.11M-7.5%3.36M0.00
Pre-tax income-118M-77.7%-66.3M+20.5%-83.3M+54.6%-183M+69.7%-604M-2018.3%
Income tax-2.50M-590.4%509K-90.5%5.34M+211.6%1.71M+114.6%-11.7M-745.4%
-112M-77.0%-63.0M+26.3%-85.5M+52.9%-182M+69.4%-593M-1853.2%
Net income to common——-85.5M+52.9%-182M+69.9%-604M-870.9%
-$0.44-63.0%-$0.27+28.9%-$0.38+55.3%-$0.85+77.6%-$3.79-325.8%
EPS (basic)-$0.44-63.0%-$0.27+28.9%-$0.38+55.3%-$0.85+77.6%-$3.79-325.8%
Weighted-avg shares (basic)255M+11.0%230M+1.6%226M+13.5%199M+31.8%151M+115.5%
Weighted-avg shares (diluted)255M+11.0%230M+1.6%226M+13.5%199M+31.8%151M+115.5%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
550M+90.5%289M+17.9%245M+3.5%237M-27.2%325M+429.4%
Cash & equivalents281M+154.6%110M+9.8%100M-18.2%123M-44.8%222M+1787.6%
Accounts receivable130M+52.5%85.5M+20.3%71.1M+113.0%33.4M-31.6%48.8M+97.0%
Inventory284K-41.1%482K+38.9%347K+22.6%283K-46.6%530K+38.0%
Prepaid expenses66.2M+142.0%27.3M+0.4%27.2M-3.5%28.2M+15.4%24.4M+495.0%
Other current assets15.3M+54.3%9.90M+35.1%7.33M+339.4%1.67M-77.1%7.30M-31.1%
1.13B+42.7%792M+2.1%776M+0.3%773M-12.8%887M+126.9%
Property, plant & equipment32.3M+70.0%19.0M+64.6%11.6M-10.3%12.9M-10.8%14.4M+188.8%
Operating lease right-of-use28.3M+278.2%7.49M+6.8%7.01M+8.5%6.46M—
Goodwill338M+3.7%326M+0.0%326M+5.2%310M-10.5%346M+72.7%
Intangible assets144M+24.8%116M-10.9%130M-13.1%149M-21.9%191M+66.9%
Long-term investments32.6M+2.7%31.7M+20.1%26.4M+11.5%23.7M0.00
Deferred tax assets1.64M+37.8%1.19M——0.00-100.0%
Other non-current assets3.48M+28.6%2.71M-44.1%4.84M-53.7%10.5M+1.3%10.3M+8.7%
353M+75.1%202M+10.2%183M+6.9%171M+12.0%153M+79.0%
Accounts payable112M+206.2%36.7M-36.1%57.4M+73.2%33.1M+66.6%19.9M+96.7%
Accrued liabilities118M+49.1%79.2M+40.5%56.3M-1.1%57.0M+1.9%55.9M+58.7%
Deferred revenue97.1M+32.3%73.4M+65.5%44.3M+0.1%44.3M+48.2%29.9M+15.0%
Short-term & current debt—19.0K+150.9%7.57K+2.3%7.41K-67.8%23.0K+123.9%
Current lease liability5.02M+67.3%3.00M-16.8%3.61M+4.3%3.46M—
Other current liabilities20.5M+119.8%9.33M-31.8%13.7M-37.8%22.0M-27.5%30.4M+717.3%
406M+84.6%220M+8.5%203M+3.1%197M+8.6%181M+0.6%
Long-term debt———7.09M-89.1%65.0M-21.4%
Non-current lease liability25.5M+467.4%4.49M+28.2%3.50M+6.6%3.28M—
Operating lease liability (total)30.5M+307.0%7.49M———
Deferred tax liabilities7.19M-47.9%13.8M-10.0%15.3M+2.2%15.0M-11.2%16.9M+108.7%
Other non-current liabilities20.3M0.00-100.0%936K0.00-100.0%11.1M+210.0%
724M+26.6%572M-0.1%573M-0.7%577M-18.3%706M+606.5%
Additional paid-in capital1.99B+17.2%1.70B+3.3%1.65B+4.9%1.57B+7.3%1.46B-14.9%
Retained earnings-1.20B-10.3%-1.09B-6.2%-1.02B-9.1%-939M-24.0%-757M-394.2%
Treasury stock17.7M+0.0%17.7M+0.0%17.7M——
Accumulated other comprehensive income-53.5M-117.3%-24.6M+25.5%-33.1M+40.1%-55.2M-31789.6%-173K-101.5%
Total liabilities & equity1.13B+42.7%792M+2.1%776M+0.3%773M-12.8%887M+126.9%
Shares outstanding (cover)10.0M-45.9%18.5M+0.0%18.5M+0.0%18.5M+0.0%18.5M
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
86.4M+5.5%81.9M+450.3%14.9M+530.6%-3.46M+94.5%-63.3M-470.8%
Depreciation & amortization70.5M-2.8%72.6M-6.1%77.3M+12.8%68.5M+15.5%59.4M+69.4%
Intangible amortization62.5M-5.4%66.1M-8.4%72.2M+13.2%63.8M+13.3%56.3M+68.6%
Deferred income taxes-7.07M-159.5%-2.72M-513.5%-444K-292.9%-113K+99.2%-13.4M-1128.3%
Change in receivables44.3M+179.3%15.9M-51.2%32.5M+469.4%-8.80M-134.1%25.8M+367.9%
-92.9M-48.2%-62.7M-31.8%-47.6M+13.2%-54.8M+58.6%-132M-484.0%
Capital expenditure21.9M+77.8%12.3M+244.4%3.57M-40.2%5.97M-7.0%6.42M+338.3%
Free cash flow64.5M-7.2%69.6M+515.3%11.3M+220.0%-9.42M+86.5%-69.7M-546.7%
Acquisitions14.8M0.000.00-100.0%20.0K-100.0%104M+2540.3%
144M+1995.2%-7.60M-1174.7%-596K-2738.1%-21.0K-100.0%410M+3964.6%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.000.000.00
Common stock issued144M0.000.000.000.00
Common stock repurchased0.000.000.000.000.00
Dividends paid0.000.000.000.000.00
FX effect on cash
————-4.14M-331.3%
Net change in cash145M+1438.4%9.45M+128.4%-33.2M+47.6%-63.4M-130.1%211M+5827.3%
Interest paid3.97M+224.1%1.22M+15200.0%8.00K——
Income taxes paid4.61M+85.9%2.48M-44.8%4.49M+118.6%2.05M-42.0%3.54M+297.5%
Source filing20-F20-F20-F20-F20-F/A

About this data

Source: GENI’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all GENI filings on SEC EDGAR → Not investment advice.